Bernard Denoyer
Directeur/Membre du Conseil chez OKYO PHARMA LIMITED
Fortune : - $ au 30/04/2024
Profil
Bernard F.
Denoyer is currently a Non-Executive Director at OKYO Pharma Ltd.
He is also a Trustee at St. Edmunds Retreat, Inc. and Midwestern Connecticut Council of Alcoholism, Inc. In the past, he worked as the Chief Financial Officer & Senior Vice President at META Group, Inc. and as the Chief Financial Officer, Secretary & Senior VP at Callisto Pharmaceuticals, Inc. He was also a Vice President-Finance at Environetics, Inc. and a Secretary & Senior Vice President at Synergy Pharmaceuticals LLC.
Additionally, he served as a Trustee at Pawfect Foods, Inc. and as the Chief Financial Officer, Secretary & Senior VP at Hepion Pharmaceuticals, Inc. Mr. Denoyer received his undergraduate degree from Fairfield University and his MBA degree from Columbia Business School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
OKYO PHARMA LIMITED
-.--% | 28/07/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Bernard Denoyer
Sociétés | Poste | Début |
---|---|---|
OKYO PHARMA LIMITED | Directeur/Membre du Conseil | 01/12/2021 |
St. Edmunds Retreat, Inc. | Directeur/Membre du Conseil | - |
Midwestern Connecticut Council of Alcoholism, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Bernard Denoyer
Sociétés | Poste | Fin |
---|---|---|
SYNERGY PHARMACEUTICALS INC | Directeur Financier/CFO | 17/04/2017 |
HEPION PHARMACEUTICALS, INC. | Directeur Financier/CFO | 23/06/2014 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Directeur Financier/CFO | 22/01/2013 |
Pawfect Foods, Inc. | Directeur Financier/CFO | 11/08/2008 |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Directeur Financier/CFO | 01/09/2000 |
Formation de Bernard Denoyer
Fairfield University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
HEPION PHARMACEUTICALS, INC. | Health Technology |
OKYO PHARMA LIMITED | Health Technology |
Entreprise privées | 7 |
---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Pawfect Foods, Inc. | Retail Trade |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Commercial Services |
Environetics, Inc.
Environetics, Inc. Wholesale DistributorsDistribution Services Part of Alanco Technologies, Inc., Environetics, Inc. is committed to improving water quality through the development of products which help to solve industrial and municipal water and wastewater quality problems. The company is based in Scottsdale, AZ. The company produces tank & clearwell baffles and covers that provide practical solutions for improving water, wastewater, and air quality. Environetics improves waste treatment by offering a quick, efficient, and satisfactory way to upgrade tank based waste treatment operations through the installation of a Director II system. Environetics was acquired by Alanco Technologies, Inc. on January 06, 1995. | Distribution Services |
St. Edmunds Retreat, Inc. | |
Midwestern Connecticut Council of Alcoholism, Inc. |